z-logo
open-access-imgOpen Access
TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB
Author(s) -
Cun-Yu Wang,
Marty W. Mayo,
Albert S. Baldwin
Publication year - 1996
Publication title -
science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 12.556
H-Index - 1186
eISSN - 1095-9203
pISSN - 0036-8075
DOI - 10.1126/science.274.5288.784
Subject(s) - apoptosis , tumor necrosis factor alpha , cancer research , nf κb , cancer cell , transcription factor , nfkb1 , cancer , pharmacology , biology , chemistry , microbiology and biotechnology , immunology , biochemistry , genetics , gene
Many cells are resistant to stimuli that can induce apoptosis, but the mechanisms involved are not fully understood. The activation of the transcription factor nuclear factor-kappa B (NF-kappaB) by tumor necrosis factor (TNF), ionizing radiation, or daunorubicin (a cancer chemotherapeutic compound), was found to protect from cell killing. Inhibition of NF-kappaB nuclear translocation enhanced apoptotic killing by these reagents but not by apoptotic stimuli that do not activate NF-kappaB. These results provide a mechanism of cellular resistance to killing by some apoptotic reagents, offer insight into a new role for NF-kappaB, and have potential for improvement of the efficacy of cancer therapies.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom